SLC7A5 and cancer: LAT1 has also been targeted with shRNA and small molecular inhibitors in a broad spectrum of cancers including esophageal squamous cell carcinoma [24], gastric cancer [25], cholangiocarcinoma [26], breast cancer [27], ovarian cancer [28], and endometrial carcinoma [29], among others.